JPMorgan Chase & Co’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,000
| Closed | -$19.4K | – | 6703 |
|
|
2024
Q1 | $19.4K | Buy |
+3,000
| New | +$19.4K | ﹤0.01% | 5243 |
|
|
2023
Q4 | – | Sell |
-3,000
| Closed | -$19.4K | – | 6953 |
|
|
2023
Q3 | $19.4K | Hold |
3,000
| – | – | ﹤0.01% | 5157 |
|
|
2023
Q2 | $19.4K | Buy |
+3,000
| New | +$19.4K | ﹤0.01% | 5046 |
|
|
2022
Q4 | – | Sell |
-3,000
| Closed | -$19K | – | 6338 |
|
|
2022
Q3 | $19K | Hold |
3,000
| – | – | ﹤0.01% | 4950 |
|
|
2022
Q2 | $19K | Buy |
+3,000
| New | +$19K | ﹤0.01% | 5075 |
|
|
2022
Q1 | – | Sell |
-3,000
| Closed | -$19K | – | 6295 |
|
|
2021
Q4 | $19K | Hold |
3,000
| – | – | ﹤0.01% | 5346 |
|
|
2021
Q3 | $19K | Hold |
3,000
| – | – | ﹤0.01% | 5152 |
|
|
2021
Q2 | $19K | Hold |
3,000
| – | – | ﹤0.01% | 5132 |
|
|
2021
Q1 | $19K | Buy |
+3,000
| New | +$19K | ﹤0.01% | 4955 |
|
|
2020
Q4 | – | Sell |
-400
| Closed | -$3K | – | 5359 |
|
|
2020
Q3 | $3K | Hold |
400
| – | – | ﹤0.01% | 4697 |
|
|
2020
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 4625 |
|
|
2020
Q1 | $3K | Buy |
+400
| New | +$3K | ﹤0.01% | 4576 |
|
|
2017
Q2 | – | Sell |
-564
| Closed | -$3K | – | 4786 |
|
|
2017
Q1 | $3K | Sell |
564
-852
| -60% | -$4.53K | ﹤0.01% | 4341 |
|
|
2016
Q4 | $8K | Sell |
1,416
-3,090
| -69% | -$17.5K | ﹤0.01% | 4288 |
|
|
2016
Q3 | $27K | Buy |
4,506
+3,984
| +763% | +$23.9K | ﹤0.01% | 3702 |
|
|
2016
Q2 | $3K | Sell |
522
-259
| -33% | -$1.49K | ﹤0.01% | 4075 |
|
|
2016
Q1 | $5K | Buy |
781
+220
| +39% | +$1.41K | ﹤0.01% | 3898 |
|
|
2015
Q4 | $3K | Buy |
+561
| New | +$3K | ﹤0.01% | 3894 |
|